ConductScience.org, home

Paper41345972

Integrated bulk and single-cell transcriptomics to develop an efferocytosis-related prognostic model for lung adenocarcinoma and validate the key gene LDHA.

Zhang W and 8 others. Eur J Med Res, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Integrated bulk and single-cell transcriptomics to develop an efferocytosis-related prognostic model for lung adenocarcinoma and validate the key gene LDHA. Papers, record 41345972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41345972

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Integrated bulk and single-cell transcriptomics to develop an efferocytosis-related prognostic model for lung adenocarcinoma and validate the key gene LDHA.
PubMed
Journal
Eur J Med Res
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-01-15
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang WWeipeng
2Chen QQuanyue
3Li YYue
4Zhang LLi
5Wang MMingxi
6Sun BBoxu
7Yang SShuo
8Yang FFan
9Dong HHaiying

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adenocarcinoma of LungMajor topic
Lung NeoplasmsMajor topic
TranscriptomeMajor topic
PhagocytosisMajor topic
L-Lactate DehydrogenaseMajor topic
Humans
Prognosis
Single-Cell Analysis
Lactate Dehydrogenase 5
Gene Expression Profiling
Biomarkers, Tumor
Gene Expression Regulation, Neoplastic
Efferocytosis

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No. LH2022H112; No. LSFGG-2024095Natural Science Foundation of Heilongjiang Province; Joint Guidance Project of the Science and Technology Plan of Qiqihar CityPubMed

Source PubMed

Download CSV of grants

References72

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
232927274Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma.EBioMedicine2020https://conductscience.org/library/papers/32927274PubMed
339788719Induction of macrophage efferocytosis in pancreatic cancer via PI3Kγ inhibition and radiotherapy promotes tumour control.Gut2025https://conductscience.org/library/papers/39788719PubMed
434292673Tumor Associated Macrophages and TAMs-Based Anti-Tumor Nanomedicines.Adv Healthc Mater2021https://conductscience.org/library/papers/34292673PubMed
530464343Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release.Nature2018https://conductscience.org/library/papers/30464343PubMed
636792751A timeline of tumour-associated macrophage biology.Nat Rev Cancer2023https://conductscience.org/library/papers/36792751PubMed
737649478Tumor-associated macrophages mediate resistance of EGFR-TKIs in non-small cell lung cancer: mechanisms and prospects.Front Immunol2023https://conductscience.org/library/papers/37649478PubMed
831350295The Tumor Microenvironment Innately Modulates Cancer Progression.Cancer Res2019https://conductscience.org/library/papers/31350295PubMed
933331847Tumor Mutation Burden and Cancer Treatment.JAMA Oncol2021https://conductscience.org/library/papers/33331847PubMed
1039987127Integration of single-cell and bulk RNA sequencing to identify a distinct tumor stem cells and construct a novel prognostic signature for evaluating prognosis and immunotherapy in LUAD.J Transl Med2025https://conductscience.org/library/papers/39987127PubMed
1138733825Silencing BMAL1 promotes M1/M2 polarization through the LDHA/lactate axis to promote GBM sensitivity to bevacizumab.Int Immunopharmacol2024https://conductscience.org/library/papers/38733825PubMed
1220808728Regularization Paths for Generalized Linear Models via Coordinate Descent.J Stat Softw2010https://conductscience.org/library/papers/20808728PubMed
1337576862Cancer stem cells in brain tumors: From origin to clinical implications.MedComm (2020)2023https://conductscience.org/library/papers/37576862PubMed
1421376230Hallmarks of cancer: the next generation.Cell2011https://conductscience.org/library/papers/21376230PubMed
1537670970NOX4-derived ROS Regulates Aerobic Glycolysis of Breast Cancer through YAP Pathway.J Cancer2023https://conductscience.org/library/papers/37670970PubMed
1637686110MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy.Int J Mol Sci2023https://conductscience.org/library/papers/37686110PubMed
1735352671EGFR Inhibitor CL-387785 Suppresses the Progression of Lung Adenocarcinoma.Curr Mol Pharmacol2023https://conductscience.org/library/papers/35352671PubMed
1835650427Drugging the efferocytosis process: concepts and opportunities.Nat Rev Drug Discov2022https://conductscience.org/library/papers/35650427PubMed
1930275043Roles of the immune system in cancer: from tumor initiation to metastatic progression.Genes Dev2018https://conductscience.org/library/papers/30275043PubMed
2040672961Prediction and immune landscape study of potentially key autophagy-related biomarkers in preeclampsia with gestational diabetes mellitus.Front Immunol2025https://conductscience.org/library/papers/40672961PubMed

See all 72 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42899246The Efferocytosis-Driven Macrophage Polarization: A Concerto in the Tumor Immunosuppressive Microenvironment.MedComm (2020)2026https://conductscience.org/library/papers/42899246PubMed
42734102Spatial and Temporal Heterogeneity of Macrophage Efferocytosis in Tumors: Emerging Implications for Immunotherapy Biomarkers and Therapeutic Timing.Cancer Med2026https://conductscience.org/library/papers/42734102PubMed
42434863LDHA, BIK, and CNIH4 Are Diagnostic Markers of Endoplasmic Reticulum Stress in Lung Cancer Comorbid With Sepsis: Integrating Machine Learning and Single-Cell Analysis of Immune Signaling.Mediators Inflamm2026https://conductscience.org/library/papers/42434863PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
LDHA3939PubTator's text mininghttps://conductscience.org/library/genes/3939NCBI Gene
SPP16696PubTator's text mininghttps://conductscience.org/library/genes/6696NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41345972

GET https://conductscience.org/api/papers/v1/41345972/references?page=2